Nature Communications (May 2025)

The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcription

  • Katharine Umphred-Wilson,
  • Shashikala Ratnayake,
  • Qianzi Tang,
  • Rui Wang,
  • Sneha Ghosh Chaudhary,
  • Devaiah N. Ballachanda,
  • Josephine Trichka,
  • Jan Wisniewski,
  • Lan Zhou,
  • Qingrong Chen,
  • Daoud Meerzaman,
  • Dinah S. Singer,
  • Stanley Adoro

DOI
https://doi.org/10.1038/s41467-025-59504-9
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Addiction to oncogene-rewired transcriptional networks is a therapeutic vulnerability in cancer cells, underscoring a need to better understand mechanisms that relay oncogene signals to the transcriptional machinery. Here, using human and mouse T cell acute lymphoblastic leukemia (T-ALL) models, we identify an essential requirement for the endosomal sorting complex required for transport protein CHMP5 in T-ALL epigenetic and transcriptional programming. CHMP5 is highly expressed in T-ALL cells where it mediates recruitment of the coactivator BRD4 and the histone acetyl transferase p300 to enhancers and super-enhancers that enable transcription of T-ALL genes. Consequently, CHMP5 depletion causes severe downregulation of critical T-ALL genes, mitigates chemoresistance and impairs T-ALL initiation by oncogenic NOTCH1 in vivo. Altogether, our findings uncover a non-oncogene dependency on CHMP5 that enables T-ALL initiation and maintenance.